MindWalk Holdings (HYFT) Free Cash Flow (2023 - 2026)
MindWalk Holdings (HYFT) reported Free Cash Flow of -$2.1 million for Q1 2026, down 175.75% year-over-year from $2.8 million in Q1 2025, and down 5.14% quarter-over-quarter from -$2.0 million in Q4 2025.
MindWalk Holdings (HYFT) Free Cash Flow (2023 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 4 years of Free Cash Flow data on file, last reported at -$2.1 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$2.1 million, down 175.75% year-over-year; the trailing twelve-month figure through Jan 2026 was -$8.7 million (down 46.93% YoY), and the FY2025 annual result was -$5.2 million, down 53.18% from the prior year.
- Free Cash Flow retreated to -$2.1 million in Q1 2026 per HYFT's latest filing, from -$2.0 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $207235.8 in Q4 2023 and troughed at -$3.5 million in Q2 2023.
- A 4-year average of -$1.7 million and a median of -$1.7 million in 2025 frame the typical range for Free Cash Flow.
- On a YoY basis, Free Cash Flow climbed as much as 63.81% in 2024 and fell as far as 869.97% in 2024.
- A 4-year view of Free Cash Flow shows it stood at $207235.8 in 2023, then tumbled by 869.97% to -$1.6 million in 2024, then dropped by 26.32% to -$2.0 million in 2025, then dropped by 5.14% to -$2.1 million in 2026.
- Business Quant data shows HYFT's Free Cash Flow at -$2.1 million in Q1 2026, -$2.0 million in Q4 2025, and -$2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 63,220.27 |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | -2.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -2.12 Mn |
| Jan 31, 2026 | -2.12 Mn |
| Oct 31, 2025 | -2.02 Mn |
| Oct 31, 2025 | -2.02 Mn |
| Jul 31, 2025 | -2.86 Mn |
| Jul 31, 2025 | -2.86 Mn |
| Apr 30, 2025 | -1.67 Mn |
| Apr 30, 2025 | -1.67 Mn |
| Jan 31, 2025 | -768,529.70 |
| Jan 31, 2025 | -768,529.70 |
| Oct 31, 2024 | -1.60 Mn |
| Oct 31, 2024 | -1.60 Mn |
| Jul 31, 2024 | -1.14 Mn |
| Jul 31, 2024 | -1.14 Mn |
| Apr 30, 2024 | -2.40 Mn |
| Apr 30, 2024 | -2.40 Mn |
| Jan 31, 2024 | -885,446.61 |
| Jan 31, 2024 | -885,446.61 |
| Oct 31, 2023 | 207,235.78 |
| Oct 31, 2023 | 207,235.78 |